A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Subjects

Trial Profile

A Double-Blind, Placebo-Controlled, Randomized, Single Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Sep 2015

At a glance

  • Drugs Pimodivir (Primary)
  • Indications Infections
  • Focus Pharmacokinetics
  • Sponsors Janssen Infectious Diseases BVBA
  • Most Recent Events

    • 21 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.govrecord.
    • 11 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov record.
    • 22 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top